Hematological effects of antiviral drugs for Hepatitis C virus

ConclusionsResults support the safety of sofosbuvir-daclatasvir regimen among Egyptians and suggest a significant role of those drug regimens in the treatment of HCV with least adverse events.
Source: QJM - Category: Internal Medicine Source Type: research